Ma Q - Search Results

1

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.

Tang C, Chen F, Kong D, Ma Q, Dai H, Yin J, Li Z, Chen J, Zhu X, Mao X, Wu D, Tang X. Tang C, et al. Among authors: ma q. J Hematol Oncol. 2018 Aug 16;11(1):103. doi: 10.1186/s13045-018-0649-6. J Hematol Oncol. 2018. PMID: 30115080 Free PMC article.

2

[The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].

Liang JY, Wu DP, Liu YJ, Ma QF, Gong JX, Zhu MQ, Xue YQ, Chen ZX. Liang JY, et al. Zhonghua Nei Ke Za Zhi. 2008 May;47(5):389-92. Zhonghua Nei Ke Za Zhi. 2008. PMID: 18953948 Chinese.

3

[Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].

Liang JY, Wu DP, Liu YJ, Ma QF, Xue YQ, Zhu MQ, Chen ZX. Liang JY, et al. Zhonghua Zhong Liu Za Zhi. 2009 Mar;31(3):196-8. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615259 Chinese.

4

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia.

Cao X, Dai H, Cui Q, Li Z, Shen W, Pan J, Shen H, Ma Q, Li M, Chen S, Chen J, Zhu X, Meng H, Yang L, Wu D, Tang X. Cao X, et al. Among authors: ma q. Exp Hematol Oncol. 2022 Sep 29;11(1):67. doi: 10.1186/s40164-022-00318-6. Exp Hematol Oncol. 2022. PMID: 36175988 Free PMC article.

5

Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase.

Cui Q, Liang P, Dai H, Cui W, Cai M, Ding Z, Ma Q, Yin J, Li Z, Liu S, Kang L, Yao L, Cen J, Shen H, Zhu M, Yu L, Wu D, Tang X. Cui Q, et al. Among authors: ma q. Front Immunol. 2022 Nov 29;13:1012981. doi: 10.3389/fimmu.2022.1012981. eCollection 2022. Front Immunol. 2022. PMID: 36524116 Free PMC article.

6

[Fluorescence in situ hybridization studies on a myeloid leukemia patient with ins(8;21)(q22;q22.1q22.3)].

Wu YF, Xue YQ, Bai SX, Zhang J, Yao L, Wang Y, Qiu HY, Shen J, Pan JL, Ma QF. Wu YF, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Apr;26(2):203-6. doi: 10.3760/cma.j.issn.1003-9406.2009.02.019. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009. PMID: 19350517 Chinese.

7

[Immunophenotypic and cytogenetic features in 51 cases of chronic lymphocytic leukemia].

Ma QF, Zhou HF, Zhu MQ, Liu DD, Chen ZX, Xue YQ. Ma QF, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Aug;15(4):696-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17708785 Chinese.

8

The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients.

Liu D, Chen Z, Xue Y, Lu D, Zhou Y, Gong J, Wu W, Liang J, Ma Q, Pan J, Wu Y, Wang Y, Zhang J, Shen J. Liu D, et al. Among authors: ma q. Leuk Res. 2009 Aug;33(8):1029-38. doi: 10.1016/j.leukres.2009.02.011. Epub 2009 May 2. Leuk Res. 2009. PMID: 19411106 Clinical Trial.

9

Truth-telling, and ethical considerations in terminal care: an Eastern perspective.

Ma Q, Wu Y, Fang R. Ma Q, et al. Nurs Ethics. 2025 Jan 9:9697330241312376. doi: 10.1177/09697330241312376. Online ahead of print. Nurs Ethics. 2025. PMID: 39786984

10

Solvent induced self-assembly of a dinuclear Eu(III) helicate and emergent strong CPL.

Wang X, Ma Q, Yin S, Gao T, Yan P, Zhou Y, Li H. Wang X, et al. Among authors: ma q. Dalton Trans. 2025 Jan 9. doi: 10.1039/d4dt02934h. Online ahead of print. Dalton Trans. 2025. PMID: 39782891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,533 results

Search Page

Filters